Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
3.030
+0.140 (4.84%)
At close: Feb 21, 2025, 4:00 PM
3.088
+0.058 (1.92%)
After-hours: Feb 21, 2025, 7:17 PM EST
Vigil Neuroscience Market Cap
Vigil Neuroscience has a market cap or net worth of $123.73 million as of February 21, 2025. Its market cap has increased by 17.30% in one year.
Market Cap
123.73M
Enterprise Value
25.64M
1-Year Change
17.30%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since the IPO on January 7, 2022, Vigil Neuroscience's market cap has decreased from $395.70M to $123.73M, a decrease of -68.73%. That is a compound annual growth rate of -31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 123.73M | 78.24% |
| Dec 31, 2024 | 69.42M | -42.76% |
| Dec 29, 2023 | 121.27M | -72.73% |
| Dec 30, 2022 | 444.76M | 12.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |